N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-(5-fluoropyrimidin-2-yl)pyrrolidine-1-carboxamide
C18H16F2N6OS — CID 153394105
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-(5-fluoropyrimidin-2-yl)pyrrolidine-1-carboxamide
N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-(5-fluoropyrimidin-2-yl)pyrrolidine-1-carboxamide (PubChem CID 153394105) has the molecular formula C18H16F2N6OS and a molecular weight of 402.43 g/mol. Its IUPAC name is N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-(5-fluoropyrimidin-2-yl)pyrrolidine-1-carboxamide.
Molecular Properties
| Compound Name | N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-(5-fluoropyrimidin-2-yl)pyrrolidine-1-carboxamide |
|---|---|
| PubChem CID | 153394105 |
| Molecular Formula | C18H16F2N6OS |
| Molecular Weight | 402.43 g/mol |
| Exact Mass | 402.11 |
| IUPAC Name | N-[3-amino-6-(5-fluorothiophen-2-yl)-2-pyridinyl]-3-(5-fluoropyrimidin-2-yl)pyrrolidine-1-carboxamide |
| SMILES | Nc1ccc(-c2ccc(F)s2)nc1NC(=O)N1CCC(c2ncc(F)cn2)C1 |
| InChI | InChI=1S/C18H16F2N6OS/c19-11-7-22-16(23-8-11)10-5-6-26(9-10)18(27)25-17-12(21)1-2-13(24-17)14-3-4-15(20)28-14/h1-4,7-8,10H,5-6,9,21H2,(H,24,25,27) |
| InChIKey | SYANXMNOMHZWAO-UHFFFAOYSA-N |
| XLogP | 3.48 |
| TPSA | 97.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.43 |
| LogP ≤ 5 | 3.48 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153394105 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.